News Conference News TCT 2023 Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80 Michael O'Riordan November 01, 2023
News Conference News TCT 2023 PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions L.A. McKeown October 31, 2023
News Conference News TCT 2022 Late Catch-up Sours SUGAR for Polymer-Free Stent in Diabetic Patients Yael L. Maxwell September 27, 2022
News Conference News TCT 2020 Fewer Events and Symptoms With iFR-Optimized PCI, Suggests DEFINE-PCI Trial Michael O'Riordan October 17, 2020
News Conference News TCT 2020 OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES L.A. McKeown October 17, 2020
News Conference News TCT 2020 IVUS-Guided PCI Gains Support With Longer-Term ULTIMATE Results Todd Neale October 15, 2020
News Conference News TCT 2020 Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk Caitlin E. Cox October 15, 2020
News Conference News TCT 2019 IVUS-XPL at 5 Years Shows Durability of Imaging Guidance in PCI Caitlin E. Cox October 08, 2019
News Conference News TCT 2019 Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II Yael L. Maxwell October 08, 2019
News Conference News TCT 2019 Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III Michael O'Riordan October 03, 2019
News Conference News TCT 2019 Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk Michael O'Riordan September 29, 2019
News Conference News TCT 2019 EXCEL at 5 Years: PCI for Left Main CAD Still Noninferior to CABG Marcus A. Banks September 28, 2019
News Conference News TCT 2018 EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis Michael O'Riordan September 21, 2018
News Industry News TCT 2016 Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI November 01, 2016
News Conference News TCT 2016 EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease Michael O'Riordan October 31, 2016
News Conference News TCT 2015 TUXEDO-India Affirms Superiority of EES in Patients With Diabetes Todd Neale October 14, 2015
News Conference News TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year L.A. McKeown November 28, 2011